BFO
CELG

Boston Family Office’s Celgene Corp CELG Stock Holding History

Boston Family Office’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-9,305
Closed -$924K – 255
2019
Q3 		$924K Sell
9,305
-2,695
-22% -$256K 0.1% 148
2019
Q2 		$1.11M Sell
12,000
-34,565
-74% -$3.28M 0.12% 137
2019
Q1 		$4.39M Sell
46,565
-61,745
-57% -$5.4M 0.47% 63
2018
Q4 		$6.94M Sell
108,310
-8,303
-7% -$613K 0.86% 44
2018
Q3 		$10.4M Sell
116,613
-4,862
-4% -$430K 1.1% 26
2018
Q2 		$9.65M Sell
121,475
-10,479
-8% -$870K 1.09% 26
2018
Q1 		$11.8M Sell
131,954
-4,131
-3% -$397K 1.34% 18
2017
Q4 		$14.2M Buy
136,085
+847
+0.6% +$95.6K 1.56% 13
2017
Q3 		$19.7M Buy
135,238
+153
+0.1% +$20.8K 2.24% 4
2017
Q2 		$17.5M Sell
135,085
-1,194
-0.9% -$146K 2.08% 4
2017
Q1 		$17M Sell
136,279
-7,561
-5% -$905K 2.08% 4
2016
Q4 		$16.6M Sell
143,840
-3,960
-3% -$441K 2.16% 5
2016
Q3 		$15.4M Buy
147,800
+2,025
+1% +$219K 2% 5
2016
Q2 		$14.4M Sell
145,775
-3,354
-2% -$347K 1.86% 8
2016
Q1 		$14.9M Sell
149,129
-1,942
-1% -$200K 1.97% 7
2015
Q4 		$18.1M Sell
151,071
-544
-0.4% -$62.9K 2.48% 2
2015
Q3 		$16.4M Sell
151,615
-2,223
-1% -$276K 2.28% 5
2015
Q2 		$17.8M Sell
153,838
-3,674
-2% -$420K 2.24% 4
2015
Q1 		$18.2M Sell
157,512
-10,198
-6% -$1.22M 2.25% 5
2014
Q4 		$18.8M Sell
167,710
-2,833
-2% -$299K 2.34% 4
2014
Q3 		$16.2M Sell
170,543
-1,947
-1% -$176K 2.08% 6
2014
Q2 		$14.8M Sell
172,490
-3,994
-2% -$304K 1.88% 7
2014
Q1 		$12.3M Sell
176,484
-4,920
-3% -$390K 1.64% 9
2013
Q4 		$15.3M Sell
181,404
-2,374
-1% -$188K 2.02% 6
2013
Q3 		$14.2M Sell
183,778
-4,680
-2% -$328K 2.02% 6
2013
Q2 		$11M Buy
+188,458
New +$11.3M 1.67% 10

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Boston Family Office's CELG Position: Q4 2019 in Review

Boston Family Office sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 9,305 shares — an estimated $924K sold.

Boston Family Office first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $19.7M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Boston Family Office reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Boston Family Office sold 9,305 Celgene Corp shares in Q4 2019, an estimated $924K.
  • Boston Family Office first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Boston Family Office's Celgene Corp position peaked at $19.7M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Boston Family Office's 13F filing for Q4 2019, filed 5 Feb 2020.